» Authors » Mick Denyer

Mick Denyer

Explore the profile of Mick Denyer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 168
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Annels N, Simpson G, Denyer M, Arif M, Coffey M, Melcher A, et al.
Mol Ther Oncolytics . 2021 Mar; 20:434-446. PMID: 33665363
Prostate cancers are considered "cold" tumors characterized by minimal T cell infiltrates, absence of a type I interferon (IFN) signature, and the presence of immunosuppressive cells. This non-inflamed phenotype is...
2.
Annels N, Mansfield D, Arif M, Ballesteros-Merino C, Simpson G, Denyer M, et al.
Clin Cancer Res . 2019 Jul; 25(19):5818-5831. PMID: 31273010
Purpose: The CANON [VATAK in -muscle-invasive bladder cancer (NMIBC)] study evaluated a novel ICAM-1-targeted immunotherapeutic-coxsackievirus A21 as a novel oncolytic agent against bladder cancer. Patients And Methods: Fifteen patients enrolled...
3.
Annels N, Arif M, Simpson G, Denyer M, Moller-Levet C, Mansfield D, et al.
Mol Ther Oncolytics . 2018 Jul; 9:1-12. PMID: 29989024
As a clinical setting in which local live biological therapy is already well established, non-muscle invasive bladder cancer (NMIBC) presents intriguing opportunities for oncolytic virotherapy. Coxsackievirus A21 (CVA21) is a...
4.
James H, Ebert K, McGonigle R, Reid S, Boonham N, Tomlinson J, et al.
J Virol Methods . 2009 Dec; 164(1-2):68-74. PMID: 19963011
A loop-mediated isothermal amplification (LAMP) assay was developed for the detection of African swine fever virus (ASFV). This assay targets the topoisomerase II gene of ASFV and its specificity was...